Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer

Overview of attention for article published in European Journal of Nuclear Medicine and Molecular Imaging, May 2003

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

patent: 6 patents

Citations

dimensions_citation: 81 Dimensions

Readers on

mendeley: 24 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 6 patents that reference this research output.

Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors

Grant US-11612667-B2

United States of America

Targeting modules for universal chimeric antigen receptor expressing immune cells and use…

Grant US-11560426-B2

United States of America

Neurotensin receptor ligands

Grant US-10961199-B2

United States of America

TARGETING MODULES FOR UNIVERSAL CHIMERIC ANTIGEN RECEPTOR EXPRESSING IMMUNE CELLS AND USE…

Application WO-2018224660-A1

World Intellectual Property Organisation (WIPO)

Neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors

Grant US-9809624-B2

United States of America

ENHANCED IN VIVO TARGETING OF RADIOLABELLED PEPTIDES WITH THE MEANS OF ENZYME INHIBITORS

Application WO-2013007660-A1

World Intellectual Property Organisation (WIPO)